- Home
- KURA vs NTB Comparison
KURA vs NTB Comparison
Compare KURA & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | NTB |
|---|---|---|
| Founded | 2014 | 1858 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.3B |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | KURA | NTB |
|---|---|---|
| Price | $10.63 | $58.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | $25.56 | ★ $53.75 |
| AVG Volume (30 Days) | ★ 1.6M | 125.6K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $0.84 |
| Revenue Next Year | $106.37 | $4.16 |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $40.59 |
| 52 Week High | $13.90 | $64.17 |
Technical Indicators
Market Signals| Indicator | KURA | NTB |
|---|---|---|
| Relative Strength Index (RSI) | 37.09 | 43.40 |
| Support Level | $8.45 | $57.98 |
| Resistance Level | $11.40 | $61.76 |
| Average True Range (ATR) | 0.50 | 1.07 |
| MACD | -0.21 | -0.07 |
| Stochastic Oscillator | 7.79 | 29.77 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.